Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

652
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
652
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

488
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
488
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.2K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

640
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
640
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

441
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
441
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

1.6K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Widespread slow growth of acquisitive tree species.

Nature·2025
Same author

Providing environmentally sustainable nephrology care: focus in low- and middle-income countries.

Kidney international·2023
Same author

Observation of Correlations between Spin and Transverse Momenta in Back-to-Back Dihadron Production at CLAS12.

Physical review letters·2023
Same author

First Measurement of Timelike Compton Scattering.

Physical review letters·2022
Same author

Exploring the Structure of the Bound Proton with Deeply Virtual Compton Scattering.

Physical review letters·2019
Same author

Direct Observation of Proton-Neutron Short-Range Correlation Dominance in Heavy Nuclei.

Physical review letters·2019

Related Experiment Video

Updated: Mar 13, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

17.2K

Recurrent IgA Nephropathy After Kidney Transplantation.

S Nijim1, V Vujjini1, S Alasfar1

  • 1Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Transplantation Proceedings
|October 30, 2016
PubMed
Summary

Recurrence of Immunoglobulin A (IgA) nephropathy after kidney transplant significantly reduces allograft survival. Younger recipients and living related donors are linked to higher IgA recurrence rates.

More Related Videos

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.2K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.6K

Related Experiment Videos

Last Updated: Mar 13, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

17.2K
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.2K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.6K

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Glomerular Diseases

Background:

  • Immunoglobulin A (IgA) nephropathy is a leading cause of kidney disease globally.
  • High rates of IgA nephropathy recurrence post-kidney transplantation pose a significant clinical challenge.
  • Understanding recurrence factors is vital for improving long-term transplant outcomes.

Purpose of the Study:

  • To evaluate the survival of kidney allografts in patients with IgA nephropathy.
  • To determine the impact of IgA recurrence on allograft function and survival.
  • To identify risk factors associated with IgA nephropathy recurrence after transplantation.

Main Methods:

  • Retrospective analysis of 104 kidney transplant recipients with IgA nephropathy between 1993 and 2014.
  • Inclusion of patients who underwent single or multiple allografts.
  • Documentation and analysis of IgA recurrence events and associated clinical data.

Main Results:

  • IgA nephropathy recurrence was observed in 19% of allografts, with a median time to recurrence of 6.75 years.
  • Younger age at transplantation (mean 37.7 years) and living related donors were associated with increased recurrence risk.
  • Allograft survival was significantly reduced in patients with recurrence (6.5 years) versus those without (10.4 years).
  • At 6 years post-transplant, 52% of the recurrence group experienced allograft failure compared to 10% in the non-recurrence group.

Conclusions:

  • Post-transplant IgA nephropathy recurrence is a major contributor to kidney allograft loss.
  • Younger recipient age and the use of living related donors are significant risk factors for recurrence.
  • Intensified monitoring and timely treatment are essential for managing IgA recurrence and preserving allograft function.